DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Children's Cetirizine Hydrochloride Allergy is a drug marketed by Actavis Mid Atlantic, Amneal Pharms, Athem, Aurobindo Pharma, Cypress Pharm, Hetero Labs Ltd Iii, Lannett Co Inc, Perrigo R And D, Pharm Assoc, Quagen, Ranbaxy Labs Ltd, Taro, Torrent, Tris Pharma Inc, Jubilant Generics, Novel Labs Inc, Sandoz, and Sun Pharm. and is included in twenty NDAs.
The generic ingredient in CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
A generic version of CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.
Recent Clinical Trials for CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
Identify potential brand extensions & 505(b)(2) entrants
|Hamad Medical Corporation||Phase 1|
|Stefania La Grutta, MD||Phase 4|
|Medical Universtity of Lodz||Phase 4|